Evidence map›Paper›PMID 40659941›Full record

ReviewProstate cancer and prostatic diseases2026

Cardiovascular risks in men with prostate cancer: a pragmatic, clinician-oriented review of risk stratification and management strategies.

Aditya Bhave, Harikrishnan Hyma Kunhiraman, Tarek Nahle, Ritu Reddy, Omar Makram, Priyanshu Nain, Viraj Shah, Umang Swami, Sagar A Patel, Ashanda Esdaille and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Prostate cancer and prostatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aditya BhaveDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0009-0001-1271-0531
Harikrishnan Hyma KunhiramanDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0000-0002-6395-7956
Tarek NahleDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0009-0004-4584-3308
Ritu ReddyDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Omar MakramDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0000-0001-8361-9068
Priyanshu NainDepartment of Medicine, AdventHealth Redmond, Rome, GA, USA.ORCID http://orcid.org/0000-0003-0008-0779
Viraj ShahDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Umang SwamiDivision of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-3518-0411
Sagar A PatelDepartment of Radiation Oncology and Urology, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-5174-2096
Ashanda EsdailleDepartment of Urology, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Martha TerrisDepartment of Urology, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0000-0002-3843-7270
Avirup GuhaDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA. aguha@augusta.edu.ORCID http://orcid.org/0000-0003-0253-1174

Funding

American Heart Association (American Heart Association, Inc.) 847740, 863620U.S. Department of Defense (United States Department of Defense) HT94252310158
6 · The paper itself

Abstract

BACKGROUND/

objectivesRecent advances in prostate cancer management have improved overall survival and quality of life for those afflicted. However, these patients continue to suffer from a high burden of cardiovascular disease through a variety of mechanisms, including both the cancer itself as well as prostate cancer-specific treatments. SUBJECTS/

methodsCardiovascular disease is now the leading cause of death in this population, and current data suggests that many patients remain sub-optimally controlled from a risk factor standpoint. There is a lack of consensus and standardized guidelines on cardiovascular risk stratification and specific management strategies in the urology, medical oncology, radiation oncology, and primary care settings. RESULTS/

conclusionsWe review available literature and provide a cardiovascular risk stratification schema for prostate cancer patients that clinicians in each of these settings can utilize. We also highlight a shared decision-making model, consistent risk restratification, and social determinants of health as care priorities to optimize cardiovascular health for this at-risk population.

Indexed as

Cardiovascular DiseasesProstatic NeoplasmsDisease ManagementHeart Disease Risk FactorsHumansMaleQuality of LifeRisk AssessmentRisk Factors

Identifiers

PMID40659941

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.